GT200400135A - Sistemas semi-solidos que contienen derivados de azetidina - Google Patents

Sistemas semi-solidos que contienen derivados de azetidina

Info

Publication number
GT200400135A
GT200400135A GT200400135A GT200400135A GT200400135A GT 200400135 A GT200400135 A GT 200400135A GT 200400135 A GT200400135 A GT 200400135A GT 200400135 A GT200400135 A GT 200400135A GT 200400135 A GT200400135 A GT 200400135A
Authority
GT
Guatemala
Prior art keywords
azetidine
systems containing
semi
containing derivatives
solid systems
Prior art date
Application number
GT200400135A
Other languages
English (en)
Inventor
Maria Teresa Peracchia
Sophie Cote
Valerie Bobineau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200400135A publication Critical patent/GT200400135A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCIÒN SE REFIERE A SISTEMAS SEMISÒLIDOS QUE CONTIENEN DERIVADOS DE AZETIDINA. ESTOS COMPUESTOS SON PARTICULARMENTE VENTAJOSOS POR SU ALTA AFINIDAD POR RECEPTORES DE CANNABINOIDES Y EN PARTICULAR POR RECEPTORES DE TIPO CB1 POR LO QUE SON DE UTILIDAD PARA UNA ACTIVA NEUROTRANSMISIÒN EN EL CEREBRO.
GT200400135A 2003-07-18 2004-07-16 Sistemas semi-solidos que contienen derivados de azetidina GT200400135A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03291796A EP1498122A1 (en) 2003-07-18 2003-07-18 Semi-solid systems containing azetidine derivatives

Publications (1)

Publication Number Publication Date
GT200400135A true GT200400135A (es) 2005-08-25

Family

ID=33462259

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200400135A GT200400135A (es) 2003-07-18 2004-07-16 Sistemas semi-solidos que contienen derivados de azetidina

Country Status (30)

Country Link
US (2) US20050026898A1 (es)
EP (2) EP1498122A1 (es)
JP (1) JP2009513560A (es)
KR (1) KR20060040691A (es)
CN (1) CN1822831A (es)
AR (1) AR045997A1 (es)
AU (1) AU2004262498B2 (es)
BR (1) BRPI0412737A (es)
CA (1) CA2532669A1 (es)
CR (1) CR8179A (es)
EC (1) ECSP066292A (es)
GT (1) GT200400135A (es)
HR (1) HRP20060022A2 (es)
IL (1) IL173111A0 (es)
MA (1) MA27922A1 (es)
MX (1) MXPA06000483A (es)
MY (1) MY142077A (es)
NO (1) NO20060509L (es)
OA (1) OA13191A (es)
PA (1) PA8606701A1 (es)
PE (1) PE20050287A1 (es)
RS (1) RS20060016A (es)
RU (1) RU2343915C2 (es)
SG (1) SG144141A1 (es)
TN (1) TNSN06013A1 (es)
TW (1) TW200522945A (es)
UA (1) UA80633C2 (es)
UY (1) UY28421A1 (es)
WO (1) WO2005013973A1 (es)
ZA (1) ZA200600490B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070084531A (ko) * 2004-11-24 2007-08-24 머크 앤드 캄파니 인코포레이티드 치환된 아미드의 경구 투여용 액체 및 반고체 약제학적제형
FR2923719B1 (fr) * 2007-11-15 2009-11-20 Sanofi Aventis Compositions pharmaceutiques a base de derives d'azetidine
CN101926757B (zh) * 2010-09-01 2013-01-02 北京大学 一种难溶性药物的液体组合物及其制备方法
AU2011327824B2 (en) * 2010-11-08 2016-06-02 Cadila Pharmaceuticals Limited Pharmaceutical composition of taxoids
CN105848643A (zh) * 2013-12-23 2016-08-10 强生消费者公司 消旋卡多曲组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0825849A1 (en) * 1995-05-19 1998-03-04 Abbott Laboratories Self-emulsifying formulations of lipophilic drugs
DE1015046T1 (de) * 1998-07-14 2001-02-08 Em Ind Inc Mikrodispersions-verabreichungssystem für arzneimittel
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6355631B1 (en) * 2000-03-03 2002-03-12 Aventis Pharma S.A. Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
FR2814678B1 (fr) * 2000-10-04 2002-12-20 Aventis Pharma Sa Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite
FR2829027A1 (fr) * 2001-08-29 2003-03-07 Aventis Pharma Sa Association avec un antagoniste du recepteur cb1, les compositions pharmaceutiques les contenant et leur utilisation pour le traitement de la maladie de parkinson
FR2833842B1 (fr) * 2001-12-21 2004-02-13 Aventis Pharma Sa Compositions pharmaceutiques a base de derives d'azetidine
EP1498123A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Emulsifying systems containing azetidine derivatives

Also Published As

Publication number Publication date
KR20060040691A (ko) 2006-05-10
TW200522945A (en) 2005-07-16
IL173111A0 (en) 2006-06-11
MA27922A1 (fr) 2006-06-01
OA13191A (en) 2006-12-13
US20080293686A1 (en) 2008-11-27
AU2004262498A1 (en) 2005-02-17
AU2004262498A2 (en) 2005-02-17
MXPA06000483A (es) 2006-04-05
AR045997A1 (es) 2005-11-23
CA2532669A1 (en) 2005-02-17
WO2005013973A1 (en) 2005-02-17
NO20060509L (no) 2006-01-31
RU2006105011A (ru) 2006-06-10
EP1498122A1 (en) 2005-01-19
MY142077A (en) 2010-08-30
US20050026898A1 (en) 2005-02-03
UA80633C2 (en) 2007-10-10
HRP20060022A2 (en) 2006-02-28
JP2009513560A (ja) 2009-04-02
ZA200600490B (en) 2007-05-30
ECSP066292A (es) 2006-10-25
TNSN06013A1 (en) 2007-10-03
RS20060016A (en) 2008-06-05
AU2004262498B2 (en) 2009-01-22
BRPI0412737A (pt) 2006-09-26
RU2343915C2 (ru) 2009-01-20
EP1648442A1 (en) 2006-04-26
SG144141A1 (en) 2008-07-29
PA8606701A1 (es) 2005-02-04
CN1822831A (zh) 2006-08-23
UY28421A1 (es) 2005-02-28
PE20050287A1 (es) 2005-06-13
CR8179A (es) 2006-09-22

Similar Documents

Publication Publication Date Title
CY1124802T1 (el) Δεσμευτικοι παραγοντες σκληροστινης
NI200600094A (es) Compuesto heterociclicos fusionados
CR8387A (es) Compuestos de pirazolilo e imidazolilo biciclicos y uso de los mismos
GT200400032A (es) Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transformante (tgf)
GT200500226A (es) Compuestos de aminoheteroarilo sustituidos con pirazol como inhibidores de proteina quinasa
BRPI0411897A (pt) pirroldihidroisoquinolinas como inibidores de pde10
PE20081506A1 (es) Formulaciones de ansamicina
HN2003000416A (es) Derivados de pirrolopirimidina
GT200200148A (es) Compuestos de heteroarilo biciclicos fusionados substituidos con heteroarilo como ligandos del receptor gaba a
BRPI0413922A (pt) xantinas de 8-heteroarila substituìda
EA200400816A1 (ru) Замещенные аналоги хиназолин-4-иламина в качестве модуляторов капсаицина
ECSP034600A (es) Compuestos de lactama
BRPI0414593A (pt) derivados de ácido sulfonamida substituìda-indol-2-carboxìlico como inibidores de pai-1
ATE427965T1 (de) Antikírper gegen 25-hydroxyvitamin d
UY28602A1 (es) Compuestos quimicos
ECSP088543A (es) Anticuerpos anti-ox40l y métodos que los utilizan
CY1105137T1 (el) Παραγωγα αμινοκυκλοεξυλ αιθερων και χρησεις τους
BRPI0414599A (pt) pirrol-indóis substituìdos
CR9786A (es) Compuestos de bencimidazol-tiofeno
PA8667201A1 (es) Nuevos compuestos farmaceuticos
ECSP045255A (es) Cumarinas utiles como biomarcadores
ATE459620T1 (de) Benzimidazolthiophenverbindungen als plk- modulatoren
GT200300072AA (es) Aminoacidos con afinidad por la proteina alfa2delta (solicitud fraccionaria
ECSP066822A (es) Macrólidos y métodos para producir los mismos
CY1115437T1 (el) Υδροξυμεθυλοκυκλοεξυλαμινες